What is “jaw necrosis” in the context of Prolia?
Prolia (denosumab) is linked to a condition called osteonecrosis of the jaw (ONJ). ONJ is damage to jaw bone that can happen when bone remodeling is suppressed for long periods. People may notice persistent jaw pain, swelling, loose teeth, exposed bone, or non-healing sores in the mouth. The risk is a known safety concern for denosumab-treated patients.
Who is most at risk of jaw necrosis from Prolia?
The risk is higher in people with factors that stress or injure the jaw or that increase ONJ likelihood, such as:
- Dental procedures that affect bone (especially tooth extractions, implants, or some surgeries)
- Poor oral health or active dental infections (like periodontitis)
- Wearing dentures that rub or cause sores
- Cancer treatments and higher-dose anti–bone resorption regimens (risk is higher in oncology settings than in osteoporosis dosing)
- Longer duration of antiresorptive therapy and other contributing medical factors (for example, smoking or certain comorbidities)
What dental symptoms should trigger medical or dental care?
Patients on Prolia should contact their dentist and prescribing clinician promptly if they have:
- Pain, swelling, or a feeling of pressure in the jaw
- Exposed bone in the mouth or a sore that does not heal
- Loose teeth not explained by typical dental causes
- Significant gum irritation or infection that keeps returning
ONJ often requires coordinated management between the dentist/oral surgeon and the prescribing clinician.
How can people lower their risk before starting Prolia?
A common practical step is a dental exam before beginning treatment, with treatment of any active dental disease first. If you already take Prolia, good oral hygiene and regular dental care matter. For planned dental work, clinicians often time or coordinate procedures to reduce risk when feasible.
Can dental procedures be done while on Prolia?
They can sometimes still be done, but the decision is individualized based on the urgency of the dental need, your ONJ risk factors, and how long you’ve been on treatment. Procedures involving bone are the main concern. Your dentist/oral surgeon and the Prolia prescriber typically plan collaboratively, weighing the benefit of the dental treatment against ONJ risk.
What happens if ONJ develops?
Management depends on severity and often includes:
- Stopping or pausing antiresorptive therapy in some cases (decisions vary by clinician and cancer/osteoporosis context)
- Local wound care, antimicrobial mouth rinses, pain control
- Treating infection and stabilizing the area
- Oral surgery only in selected cases, usually under an oral surgeon familiar with ONJ
Because untreated infections can worsen, prompt evaluation is important.
Is there a difference between Prolia-related ONJ and “bisphosphonate” jaw necrosis?
Both bisphosphonates and denosumab are linked to ONJ, but Prolia is a monoclonal antibody (denosumab) rather than a bisphosphonate. In practice, the risk profile and prevention approach overlap: dental evaluation, good oral health, and caution around invasive dental procedures are central.
How long does Prolia-related jaw necrosis risk last?
ONJ risk is associated with ongoing suppression of bone remodeling and may persist even after stopping treatment, so risk-reduction habits (oral hygiene, prompt dental care, and careful planning of procedures) remain important over time. The exact duration of elevated risk varies by individual and treatment history.
Questions to ask your dentist or prescriber
If you’re on Prolia (or starting it) and considering dental work, useful questions include:
- Do I need a dental exam and any preventive treatment before my next Prolia dose?
- Is my planned procedure likely to involve bone, and how can we reduce ONJ risk?
- Given my risk factors, what signs should prompt urgent evaluation?
- Who should coordinate between my dentist and the clinician managing Prolia?
If you tell me your situation, I can tailor the risk discussion
If you share (1) whether you take Prolia for osteoporosis or cancer-related bone involvement, (2) how long you’ve been on it, and (3) any planned dental procedure or current symptoms, I can help you map the typical risk considerations and next steps to discuss with your care team.